"Le Centre Hospitalier Saint Joseph Saint Luc est un Etablissement de Santé Privé d’Intérêt Collectif (ESPIC) de centre-ville qui compte 360 lits d’hospitalisation et places d’ambulatoire. Il emploie environ 1000 salariés et réalise près de 2200 naissances par an au sein de sa Maternité. A but non lucratif, il exerce une mission de service public sur l’ensemble de ses activités. Ses patients bénéficient d’une « tarification publique » : sans « reste à charge » et sans aucun dépassement d’honoraires."

During the past decade, Centre Hospitalier Saint Joseph Saint Luc conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Saint Joseph Saint Luc" #1 sponsor was "Centre Hospitalier Saint Joseph Saint Luc de Lyon" with 8 trials, followed by "Federation Francophone de Cancerologie Digestive" with 5 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 5 trials sponsored, "Hospices Civils de Lyon" with 4 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 4 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Saint Joseph Saint Luc" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "University Hospital, Grenoble" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Saint Joseph Saint Luc" are "Coronary Artery Disease" (4 trials), "Colorectal Cancer" (3 trials), "Myocardial Infarction" (3 trials), "Diabetes" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Centre Hospitalier Saint Joseph Saint Luc" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Saint Joseph Saint Luc" are "Drug" (25 trials), "Other" (14 trials), "Device" (12 trials), "Procedure" (12 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "ICD" (3 trials), "Placebo" (3 trials), "Folinic Acid" (2 trials) and "Oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Saint Joseph Saint Luc" are 63 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Saint Joseph Saint Luc". 3 are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Centre Hospitalier Saint Joseph Saint Luc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Saint Joseph Saint Luc, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 16 trials that are defined as “Not Applicable".

Centre Hospitalier Saint Joseph Saint Luc has several departments that took part in Clinical trials: "Ctre Hosp St Joseph Et St Luc; Gastro Enterologie Endoscopie" - 2 trials